| 471 |
Design, synthesis and mechanistic study of new 1,2,4-triazole derivatives as antimicrobial agents |
|
2021 |
| 472 |
Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 473 |
Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 474 |
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 475 |
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 476 |
Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4- (methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors |
|
2021 |
| 477 |
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors |
Department of Pharmaceutical Organic Chemistry |
2021 |
| 478 |
Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles |
Department of Pharmaceutics |
2021 |
| 479 |
Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles |
Department of Pharmaceutics |
2021 |
| 480 |
Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles |
Department of Pharmaceutics |
2021 |